We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-1.1%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.53B
AUM Growth
+$93.1M
(+1.1%)
Cap. Flow
+$472M
Cap. Flow
% of AUM
5.53%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
812
New
193
Increased
197
Reduced
149
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$188M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
Electronic Arts
EA
|
+$112M |
| 4 |
Autodesk
ADSK
|
+$97.3M |
| 5 |
Keysight
KEYS
|
+$92.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$123M |
| 2 |
Amphenol
APH
|
+$113M |
| 3 |
Cencora
COR
|
+$108M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
HP
HPQ
|
+$91.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.52% |
| 2 | Technology | 26.19% |
| 3 | Industrials | 9.44% |
| 4 | Energy | 7.95% |
| 5 | Consumer Discretionary | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Biohaven
BHVN
$2.07B
| $13.9M | 0.16% |
536,073
+244,492
| +84% | +$5.08M |
|
|
SEE
177
DELISTED
Sealed Air
SEE
| $13.9M | 0.16% |
423,165
+263,348
| +165% | +$10.2M |
|
178
BioNTech
BNTX
$23.1B
| $13.9M | 0.16% |
127,560
+81,760
| +179% | +$9.04M |
|
179
Bristol-Myers Squibb
BMY
$135B
| $13.8M | 0.16% |
237,480
+37,280
| +19% | +$2.28M |
|
180
Edgewell Personal Care
EPC
$1.31B
| $13.7M | 0.16% |
371,700
-81,104
| -18% | -$3.13M |
|
181
New York Times
NYT
$12.2B
| $13.6M | 0.16% |
+331,080
| New | +$13.9M |
|
182
Lennox International
LII
$15.4B
| $13.5M | 0.16% |
+36,002
| New | +$13M |
|
183
Marvell Technology
MRVL
$196B
| $13.5M | 0.16% |
+248,983
| New | +$14.7M |
|
184
Alibaba
BABA
$309B
| $13.4M | 0.16% |
+154,526
| New | +$14.1M |
|
185
Super Micro Computer
SMCI
$20.5B
| $13.4M | 0.16% |
+487,150
| New | +$13.6M |
|
186
Home Depot
HD
$347B
| $13.3M | 0.16% |
44,146
+14,469
| +49% | +$4.65M |
|
187
NetEase
NTES
$83.6B
| $13.3M | 0.16% |
132,750
+58,163
| +78% | +$5.96M |
|
188
Acadia Healthcare
ACHC
$2.95B
| $13.1M | 0.15% |
186,554
+126,658
| +211% | +$9.46M |
|
|
AZPN
189
DELISTED
Aspen Technology Inc
AZPN
| $13M | 0.15% |
63,624
-2,638
| -4% | -$497K |
|
190
Take-Two Interactive
TTWO
$44.9B
| $13M | 0.15% |
92,276
-14,593
| -14% | -$2.1M |
|
191
Lennar Class A
LEN
$21B
| $12.9M | 0.15% |
119,072
+29,401
| +33% | +$3.45M |
|
192
Colgate-Palmolive
CL
$73.8B
| $12.6M | 0.15% |
+177,556
| New | +$13.3M |
|
193
Arrowhead Research
ARWR
$12.6B
| $12.6M | 0.15% |
468,497
+372,530
| +388% | +$11.4M |
|
194
Humana
HUM
$43.5B
| $12.5M | 0.15% |
+25,700
| New | +$12.1M |
|
195
TransDigm Group
TDG
$71.3B
| $12.5M | 0.15% |
14,821
+12,564
| +557% | +$11M |
|
|
ACCD
196
DELISTED
Accolade Inc
ACCD
| $12.4M | 0.15% |
+1,175,792
| New | +$15.4M |
|
197
Wendy's
WEN
$1.46B
| $12.3M | 0.14% |
+603,953
| New | +$12.6M |
|
198
Paycom
PAYC
$8.17B
| $12.3M | 0.14% |
47,349
-13,378
| -22% | -$4.08M |
|
|
MRTX
199
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $12.1M | 0.14% |
278,223
-95,109
| -25% | -$3.4M |
|
200
Core & Main
CNM
$8.67B
| $12.1M | 0.14% |
419,794
+336,894
| +406% | +$10.4M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Woodline Partners held 812 positions worth $8.53B, up 1.1% from $8.44B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners deployed $472M of net new capital in Q3 2023, opening 193 new positions and adding to 197 existing holdings. Its largest new stake was Analog Devices: 1,016,972 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Hess, an estimated $123M trimmed.
- Woodline Partners's largest Q3 2023 buy was Analog Devices: 1,016,972 shares worth $178M.
- Woodline Partners added most to AbbVie in Q3 2023, an estimated $121M increase.
- Woodline Partners's biggest Q3 2023 reduction was Hess, cutting an estimated $123M.
- Woodline Partners fully exited HP in Q3 2023, selling an estimated $91.2M.
- Woodline Partners's ten largest holdings make up 17% of its $8.53B portfolio in Q3 2023.
- Woodline Partners opened 193 new positions and closed 231 in Q3 2023.
- Woodline Partners's portfolio value rose 1.1% quarter-over-quarter to $8.53B.
Based on Woodline Partners's 13F filing for Q3 2023, filed 14 Nov 2023.